ICON is proud to sponsor the SOLAR conference. Our hepatology specialists will be on-site (25-27 June), talking with peers about the practical side of running liver disease trials from AI-driven site selection to imagi...

Last week, we proudly celebrated a significant milestone, 30 years of ICON Germany. Over the past three decades, our teams in Germany have played an important role in advancing clinical research and supporting customer...

Celebrating 20 years of ICON in Poland. Since our Polish branch was established in Warsaw in 2006, ICON Poland has grown into a team of more than 1,800 employees across Warsaw, Gdańsk, and remote working locations. Ove...

Biologic viral safety is entering a new phase. Updated global ICH guidance is reshaping how manufacturers approach risk based controls, modern analytics and manufacturing innovation. In this PharmTech feature, John M. e...

Access to high-performing sites is a key differentiator for study success. ICON’s premium site network model connects sponsors with experienced, motivated sites, improving enrolment, quality and delivery timelines. Join ...

Implementing digital innovations early in the planning phase is critical to avoiding prolonged vaccine trial cycles. Read the article to learn how AI is helping developers outpace traditional operational hurdles: https:/...

Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our fr...

Integrating artificial intelligence into vaccine trials dramatically improves predictive modeling and multi-regional data analysis. Discover how advanced tech is optimising modern vaccine pipelines in our latest article:...

Delays at study start-up continue to impact overall timelines. ICON is focused on accelerating site activation through better planning, stronger site engagement and streamlined processes. Join us at DIA Philadelphia, Bo...

A technology-driven mindset is redefining traditional vaccine development timelines. Explore insights from ICON’s Dinah Knotts-Keeterle in this new article in The Journal of mHealth, highlighting how AI is helping resear...

Regulatory complexity is increasing across regions, modalities and trial designs. ICON’s Regulatory Affairs team brings the strategic expertise needed to navigate evolving requirements, reduce risk and keep programmes on...

Join ICON's Praneeth Adidela at #PharmaSUG US on 2 June for an insightful presentation on utilising R within SAS LSAF (Life Science Analytics Framework). This session will offer practical guidance on maintaining complian...